Diabetes Drug Shows Benefit in Parkinson’s Disease

Source link : https://www.newshealth.biz/health-news/diabetes-drug-shows-benefit-in-parkinsons-disease/

The glucagon-like peptide-1 (GLP-1) receptor agonist lixisenatide (Adlyxin) led to less progression of motor disability compared with placebo in early Parkinson’s disease, the phase II LIXIPARK trial showed. At 12 months, motor scores on the Movement Disorder Society-Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) part III improved by 0.04 points in the lixisenatide group and worsened […]

Author : News Health

Publish date : 2024-04-03 21:20:35

Copyright for syndicated content belongs to the linked Source.